The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective identification of prognostic factors for patients with early failure of advanced ovarian cancer who undergo primary cytoreductive surgery followed by chemotherapy: The AGO-OVAR 19/FRAGILE study (NCT02828618).
 
Felix Hilpert
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; PharmaMar
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD
 
Alexander Burges
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Roche; Tesaro
 
Bernhard Kraemer
Honoraria - Gedeon Richter; Medtronic
Consulting or Advisory Role - PlantTec Medical
Travel, Accommodations, Expenses - BOWA
 
Britta Oerke
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Bayer; Clovis Oncology; Eisai; GlaxoSmithKline; Johnson & Johnson; MSD Oncology; Olympus Medical Systems; Pfizer; PharmaMar; Tesaro; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Ingress Health; Johnson & Johnson; Lilly; Merck; MSD Oncology; Novartis; Novocure; Pfizer; PharmaMar; Riemser; Roche; Sobi; Tesaro
Research Funding - AstraZeneca (Inst); Bayer (Inst); Clovis Oncology (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); PharmaMar (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD Oncology; Olympus; PharmaMar; Roche Pharma AG; Tesaro; Tesaro
 
Bjoern Lampe
No Relationships to Disclose
 
Barbara Schmalfeldt
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; MSD; Roche; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; MSD; Roche; Tesaro
Research Funding - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche; Tesaro
 
Pauline Wimberger
Honoraria - Amgen; AstraZeneca; Eisai; MSD Oncology; Novartis/Pfizer; Pfizer; Roche Pharma AG
Consulting or Advisory Role - Amgen; AstraZeneca; MSD Oncology; Novartis; PharmaMar; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - Roche Pharma AG
 
Ralf Witteler
Consulting or Advisory Role - Eisai; MSD; Roche; Tesaro/GSK
Research Funding - MSD; Tesaro/GSK
Travel, Accommodations, Expenses - GlaxoSmithKline; Tesaro
 
Paul Buderath
Honoraria - AstraZeneca/Daiichi Sankyo; Roche
Consulting or Advisory Role - Roche
 
Uwe Herwig
Consulting or Advisory Role - Roche
 
Holger Bronger
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; Roche
Consulting or Advisory Role - GlaxoSmithKline; Roche
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
 
Andreas Mueller
No Relationships to Disclose
 
Alexander Reuss
No Relationships to Disclose
 
Norbert Peters
No Relationships to Disclose
 
Volker Hanf
Stock and Other Ownership Interests - BioNTech; Moderna Therapeutics
 
Andreas Du Bois
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; Ingress Health; Mersana; Roche/Genentech; Zodiac Pharma
 
Philipp Harter
Honoraria - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; MSD Oncology; Roche; Sotio; Stryker; Zai Lab
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Merck; Roche; Tesaro
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Roche (Inst)
 
Sven Mahner
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Janssen-Cilag; Jenapharm; Medac; Novartis/Pfizer; PharmaMar; Roche/Genentech; Teva
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Immunogen; Janssen-Cilag; Medac; Merck Sharp & Dohme; Roche; Sensor-Kinesis Corp.; Tesaro
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Medac; PharmaMar; Roche; Tesaro
 
Florian Heitz
Honoraria - AstraZeneca; Roche; Tesaro/GSK
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Novocure; PharmaMar; Roche
Research Funding - Amedes (Inst); AstraZeneca (Inst)